Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients - Heise, T; Graefe-Mody, E U; Huttner, S (Diabetes Obes Metab, 2009)
et al.